Immunicum is listed on NASDAQ OMX First North Premier under the ticker IMMU.
Tweets by @ImmunicumTweets by Immunicum
- 17 Nov 2017
Immunicum AB (publ) and Academic Collaborators Publish Preclinical Ilixadencel Mode of Action Data in Journal Oncoimmunology10 Nov 2017
Immunicum AB (publ) Presents Further Preclinical Ilixadencel Mode of Action Data at Annual SITC Meeting07 Nov 2017
Developing innovative cancer immunotherapies
We are on a journey towards the world’s first patient unique, off-the-shelf cancer treatment. Get to know the technology that will take us there.Learn more